Nanoparticles for topical drug delivery: Potential for skin cancer treatment.
Administration, Cutaneous
Antineoplastic Agents
/ administration & dosage
Dacarbazine
/ pharmacology
Drug Carriers
/ administration & dosage
Fluorouracil
/ pharmacology
Gold
/ chemistry
Humans
Metal Nanoparticles
/ administration & dosage
Nanoparticles
/ administration & dosage
Skin Absorption
/ physiology
Skin Neoplasms
/ drug therapy
Skin Physiological Phenomena
Actinic keratosis
Basal cell carcinoma
Dermatology
Drug delivery
Nanomedicine
Nanoparticles
Nanotechnology
Skin
Squamous cell carcinoma
Topical
Journal
Advanced drug delivery reviews
ISSN: 1872-8294
Titre abrégé: Adv Drug Deliv Rev
Pays: Netherlands
ID NLM: 8710523
Informations de publication
Date de publication:
01 01 2020
01 01 2020
Historique:
received:
23
09
2019
revised:
25
05
2020
accepted:
29
05
2020
pubmed:
5
6
2020
medline:
9
9
2021
entrez:
5
6
2020
Statut:
ppublish
Résumé
Nanoparticles offer new opportunities for the treatment of skin diseases. The barrier function of the skin poses a significant challenge for nanoparticles to permeate into the tissue, although the barrier is partially compromised in case of injury or inflammation, as in the case of skin cancer. This may facilitate the penetration of nanoparticles. Extensive research has gone into developing nanoparticles for topical delivery; however, relatively little progress has been made in translating them to the clinic for treating skin cancers. We summarize the types of skin cancers and practices in current clinical management. The review provides a comprehensive outlook of the various nanoparticle technologies tested for topical therapy of skin cancers and summarizes the obstacles that impede its progress from the bench-to-bedside. The review also aims to provide an understanding of the pathways that govern nanoparticle penetration into the skin and a critical analysis of the approaches used to study nanoparticle interactions within the tissue.
Identifiants
pubmed: 32497707
pii: S0169-409X(20)30044-2
doi: 10.1016/j.addr.2020.05.011
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Drug Carriers
0
Gold
7440-57-5
Dacarbazine
7GR28W0FJI
Fluorouracil
U3P01618RT
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
87-108Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.